PROM1 and central nervous system cancer: To confirm our results, we also analyzed glioma tissues from The Cancer Genome Atlas (Figure 1I) and the Chinese Glioma Genome Atlas (Figure 1J), and found that greater CD133 expression was associated with poorer survival in glioma patients.